Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
AO is a director of Tandem Nano and co-inventor of drug delivery patents unrelated to medicines discussed in this Correspondence. AO has been co-investigator on funding received by the University of Liverpool from ViiV Healthcare and Gilead Sciences unrelated to COVID-19 in the past 3 years. AO has received personal fees from Gilead and Assembly Biosciences in the past 3 years unrelated to COVID-19 research. AO is a member of the Trial Management Group for the AGILE phase 1/2 platform trial and AGILE has received funding from Ridgeback and GlaxoSmithKline in the past 3 years for which AO was not a co-investigator. These disclosures were reviewed by WHO before discussions with the GDG who deemed them not to present a conflict of interest. All other authors declare no competing interests.